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Abstract: Artificial intelligence in healthcare is an overarching term used to describe the use of machine-
learning algorithms and software, or artificial intelligence (AI), to mimic human cognition in the analysis, 
presentation, and comprehension of complex medical and health care data. Specifically, AI is the ability 
of computer algorithms to approximate conclusions based solely on input data. This paper presents a 
review study on role of AI in healthcare in short. 
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INTRODUCTION 
The primary aim of health-related AI applications 
is to analyze relationships between prevention or 
treatment techniques and patient outcomes. AI 
programs are applied to practices such 
as diagnosis processes, treatment 
protocol development, drug 
development, personalized medicine, and patient 
monitoring and care. AI algorithms can also be 
used to analyze large amounts of data through 
electronic health records for disease prevention and 
diagnosis. Medical institutions such as The Mayo 
Clinic, Memorial Sloan Kettering Cancer 
Center, and the British National Health 
Service, have developed AI algorithms for their 
departments. Large technology companies such 
as IBM and Google, have also developed AI 
algorithms for healthcare. Additionally, hospitals 
are looking to AI software to support operational 
initiatives that increase cost saving, improve patient 
satisfaction, and satisfy their staffing and 
workforce needs. Currently, the United States 
government is investing billions of dollars to 
progress the development of AI in 
healthcare. Companies are developing technologies 
that help healthcare managers improve business 
operations through increasing utilization, 
decreasing patient boarding, reducing length of stay 
and optimizing staffing levels. 
Research in the 1960s and 1970s produced the first 
problem-solving program, or expert system, known 
as Dendral. While it was designed for applications 
in organic chemistry, it provided the basis for a 
subsequent system MYCIN, considered one of the 
most significant early uses of artificial intelligence 
in medicine. MYCIN and other systems such as 
INTERNIST-1 and CASNET did not achieve 
routine use by practitioners, however. 
The 1980s and 1990s brought the proliferation of 
the microcomputer and new levels of network 
connectivity. During this time, there was a 
recognition by researchers and developers that AI 
systems in healthcare must be designed to 
accommodate the absence of perfect data and build 
on the expertise of physicians. Approaches 
involving fuzzy set theory, Bayesian 
networks, and artificial neural networks, have been 
applied to intelligent computing systems in 
healthcare. 
Medical and technological advancements occurring 
over this half-century period that have enabled the 
growth healthcare-related applications of AI 
include: 
 Improvements in computing power resulting 
in faster data collection and data processing 
 Growth of genomic sequencing databases 
 Widespread implementation of electronic 
health record systems 
 Improvements in natural language 
processing and computer vision, enabling 
machines to replicate human perceptual 
processes 
 Enhanced the precision of robot-assisted 
surgery 
 Improvements in deep learning techniques 
and data logs in rare diseases 
Various specialties in medicine have shown an 
increase in research regarding AI. 
Dermatology 
Dermatology is an imaging abundant speciality and 
the development of deep learning has been strongly 
tied to image processing. Therefore there is a 
natural fit between the dermatology and deep 
learning. There are 3 main imaging types in 
dermatology: contextual images, macro images, 
micro images. For each modality, deep learning 
showed great progress. Han et. al. showed 
keratinocytic skin cancer detection from face 
photographs. Esteva et al. demonstrated 
dermatologist-level classification of skin cancer 
from lesion images. Noyan et. al. demonstrated 
a convolutional neural network that achieved 94% 
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accuracy at identifying skin cells from 
microscopic Tzanck smear images. 
Radiology 
AI is being studied within the radiology field to 
detect and diagnose diseases within patients 
through Computerized Tomography (CT) 
and Magnetic Resonance (MR) Imaging. The focus 
on Artificial Intelligence in radiology has rapidly 
increased in recent years according to the 
Radiology Society of North America, where they 
have seen growth from 0 to 3, 17, and overall 10% 
of total publications from 2015-2018 
respectively. A study at Stanford created an 
algorithm that could detect pneumonia in patients 
with a better average F1 metric (a statistical metric 
based on accuracy and recall), than radiologists 
involved in the trial. Through imaging in oncology, 
AI has been able to serve well for detecting 
abnormalities and monitoring change over time; 
two key factors in oncological health. Many 
companies and vendor neutral systems such as 
icometrix, QUIBIM, Robovision, and UMC 
Utrecht’s IMAGRT have become available to 
provide a trainable machine learning platform to 
detect a wide range of diseases. The Radiological 
Society of North America has implemented 
presentations on AI in imaging during its annual 
conference. Many professionals are optimistic 
about the future of AI processing in radiology, as it 
will cut down on needed interaction time and allow 
doctors to see more patients. Although not always 
as good as a trained eye at deciphering malicious or 
benign growths, the history of medical imaging 
shows a trend toward rapid advancement in both 
capability and reliability of new systems. The 
emergence of AI technology in radiology is 
perceived as a threat by some specialists, as it can 
improve by certain statistical metrics in isolated 
cases, where specialists cannot. 
Screening 
Recent advances have suggested the use of AI to 
describe and evaluate the outcome of maxillo-facial 
surgery or the assessment of cleft palate therapy in 
regard to facial attractiveness or age appearance. 
In 2018, a paper published in the journal Annals of 
Oncology mentioned that skin cancer could be 
detected more accurately by an artificial 
intelligence system (which used a deep learning 
convolutional neural network) than 
by dermatologists. On average, the human 
dermatologists accurately detected 86.6% of skin 
cancers from the images, compared to 95% for the 
CNN machine. 
In January 2020 researchers demonstrate an AI 
system, based on a Google DeepMind algorithm, 
that is capable of surpassing human experts 
in breast cancer detection. 
In July 2020 it was reported that an AI algorithm 
by the University of Pittsburgh achieves the highest 
accuracy to date in identifying prostate cancer, with 
98% sensitivity and 97% specificity. 
Psychiatry 
In psychiatry, AI applications are still in a phase of 
proof-of-concept. Areas where the evidence is 
widening quickly include chatbots, conversational 
agents that imitate human behaviour and which 
have been studied for anxiety and depression. 
Challenges include the fact that many applications 
in the field are developed and proposed by private 
corporations, such as the screening for suicidal 
ideation implemented by Facebook in 2017. Such 
applications outside the healthcare system raise 
various professional, ethical and regulatory 
questions. 
Primary care 
Primary care has become one key development 
area for AI technologies. AI in primary care has 
been used for supporting decision making, 
predictive modelling, and business 
analytics. Despite the rapid advances in AI 
technologies, general practitioners' view on the role 
of AI in primary care is very limited–mainly 
focused on administrative and routine 
documentation tasks. 
Disease diagnosis 
An article by Jiang, et al. (2017) demonstrated that 
there are several types of AI techniques that have 
been used for a variety of different diseases, such 
as support vector machines, neural networks, and 
decision trees. Each of these techniques is 
described as having a “training goal” so 
“classifications agree with the outcomes as much as 
possible…”. 
To demonstrate some specifics for disease 
diagnosis/classification there are two different 
techniques used in the classification of these 
diseases include using “Artificial Neural Networks 
(ANN) and Bayesian Networks (BN)”. It was 
found that ANN was better and could more 
accurately classify diabetes and CVD. Through the 
use of Medical Learning Classifiers (MLC’s), 
Artificial Intelligence has been able to substantially 
aid doctors in patient diagnosis through the 
manipulation of mass Electronic Health 
Records (EHR’s). Medical conditions have grown 
more complex, and with a vast history of electronic 
medical records building, the likelihood of case 
duplication is high. Although someone today with a 
rare illness is less likely to be the only person to 
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have suffered from any given disease, the inability 
to access cases from similarly symptomatic origins 
is a major roadblock for physicians. The 
implementation of AI to not only help find similar 
cases and treatments, but also factor in chief 
symptoms and help the physicians ask the most 
appropriate questions helps the patient receive the 
most accurate diagnosis and treatment possible. 
Telemedicine 
An elderly man using a pulse oximeter to measure 
his blood oxygen levels The increase 
of telemedicine, the treatment of patients remotely, 
has shown the rise of possible AI applications. AI 
can assist in caring for patients remotely by 
monitoring their information through sensors. A 
wearable device may allow for constant monitoring 
of a patient and the ability to notice changes that 
may be less distinguishable by humans. The 
information can be compared to other data that has 
already been collected using artificial intelligence 
algorithms that alert physicians if there are any 
issues to be aware of. 
Another application of artificial intelligence is in 
chat-bot therapy. Some researchers charge that the 
reliance on chat-bots for mental healthcare does not 
offer the reciprocity and accountability of care that 
should exist in the relationship between the 
consumer of mental healthcare and the care 
provider (be it a chat-bot or psychologist), though. 
Since the average age has risen due to a longer life 
expectancy, artificial intelligence could be useful in 
helping take care of older populations. Tools such 
as environment and personal sensors can identify a 
person’s regular activities and alert a caretaker if a 
behavior or a measured vital is abnormal. Although 
the technology is useful, there are also discussions 
about limitations of monitoring in order to respect a 
person’s privacy since there are technologies that 
are designed to map out home layouts and detect 
human interactions. 
Electronic health records 
Electronic health records (EHR) are crucial to the 
digitalization and information spread of the 
healthcare industry. Now that around 80% of 
medical practices use EHR, the next step is to use 
artificial intelligence to interpret the records and 
provide new information to physicians. One 
application uses natural language processing (NLP) 
to make more succinct reports that limit the 
variation between medical terms by matching 
similar medical terms. For example, the term heart 
attack and myocardial infarction mean the same 
things, but physicians may use one over the over 
based on personal preferences. NLP algorithms 
consolidate these differences so that larger datasets 
can be analyzed. Another use of NLP identifies 
phrases that are redundant due to repetition in a 
physician’s notes and keeps the relevant 
information to make it easier to read. Beyond 
making content edits to an EHR, there are AI 
algorithms that evaluate an individual patient’s 
record and predict a risk for a disease based on 
their previous information and family history. One 
general algorithm is a rule-based system that makes 
decisions similarly to how humans use flow 
charts.This system takes in large amounts of data 
and creates a set of rules that connect specific 
observations to concluded diagnoses. Thus, the 
algorithm can take in a new patient’s data and try to 
predict the likeliness that they will have a certain 
condition or disease. Since the algorithms can 
evaluate a patient’s information based on collective 
data, they can find any outstanding issues to bring 
to a physician’s attention and save time. One study 
conducted by the Centerstone research institute 
found that predictive modeling of EHR data has 
achieved 70–72% accuracy in predicting 
individualized treatment response. These methods 
are helpful due to the fact that the amount of online 
health records doubles every five years. Physicians 
do not have the bandwidth to process all this data 
manually, and AI can leverage this data to assist 
physicians in treating their patients. 
Drug Interactions 
Improvements in natural language processing led to 
the development of algorithms to identify drug-
drug interactions in medical literature. Drug-drug 
interactions pose a threat to those taking multiple 
medications simultaneously, and the danger 
increases with the number of medications being 
taken. To address the difficulty of tracking all 
known or suspected drug-drug interactions, 
machine learning algorithms have been created to 
extract information on interacting drugs and their 
possible effects from medical literature. Efforts 
were consolidated in 2013 in the DDIExtraction 
Challenge, in which a team of researchers at Carlos 
III University assembled a corpus of literature on 
drug-drug interactions to form a standardized test 
for such algorithms. Competitors were tested on 
their ability to accurately determine, from the text, 
which drugs were shown to interact and what the 
characteristics of their interactions were. 
Researchers continue to use this corpus to 
standardize the measurement of the effectiveness of 
their algorithms. Other algorithms identify drug-
drug interactions from patterns in user-generated 
content, especially electronic health records and/or 
adverse event reports. Organizations such as the 
FDA Adverse Event Reporting System (FAERS) 
and the World Health Organization's VigiBase 
allow doctors to submit reports of possible negative 
reactions to medications. Deep learning algorithms 
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have been developed to parse these reports and 
detect patterns that imply drug-drug interactions. 
Creation of new drugs 
DSP-1181, a molecule of the drug for OCD 
(obsessive-compulsive disorder) treatment, was 
invented by artificial intelligence through joint 
efforts of Exscientia (British start-up) and 
Sumitomo Dainippon Pharma (Japanese 
pharmaceutical firm). The drug development took a 
single year, while pharmaceutical companies 
usually spend about five years on similar projects. 
DSP-1181 was accepted for a human trial. In 
September 2019 Insilico Medicine reports the 
creation, via artificial intelligence, of six novel 
inhibitors of the DDR1 gene, a kinase target 
implicated in fibrosis and other diseases. The 
system, known as Generative Tensorial 
Reinforcement Learning (GENTRL), designed the 
new compounds in 21 days, with a lead candidate 
tested and showing positive results in mice. The 
same month Canadian company Deep Genomics 
announces that its AI-based drug discovery 
platform has identified a target and drug candidate 
for Wilson's disease. The candidate, DG12P1, is 
designed to correct the exon-skipping effect of 
Met645Arg, a genetic mutation affecting the 
ATP7B copper-binding protein. 
Industry 
The trend of large health companies merging 
allows for greater health data accessibility. Greater 
health data lays the groundwork for implementation 
of AI algorithms. A large part of industry focus of 
implementation of AI in the healthcare sector is in 
the clinical decision support systems. As more data 
is collected, machine learning algorithms adapt and 
allow for more robust responses and solutions. 
Numerous companies are exploring the possibilities 
of the incorporation of big data in the healthcare 
industry. Many companies investigate the market 
opportunities through the realms of “data 
assessment, storage, management, and analysis 
technologies” which are all crucial parts of the 
healthcare industry. 
The following are examples of large companies 
that have contributed to AI algorithms for use in 
healthcare: 
• IBM's Watson Oncology is in development at 
Memorial Sloan Kettering Cancer Center and 
Cleveland Clinic. IBM is also working with 
CVS Health on AI applications in chronic 
disease treatment and with Johnson & 
Johnson on analysis of scientific papers to 
find new connections for drug development. 
In May 2017, IBM and Rensselaer 
Polytechnic Institute began a joint project 
entitled Health Empowerment by Analytics, 
Learning and Semantics (HEALS), to explore 
using AI technology to enhance healthcare. 
• Microsoft's Hanover project, in partnership 
with Oregon Health & Science University's 
Knight Cancer Institute, analyzes medical 
research to predict the most effective cancer 
drug treatment options for patients. Other 
projects include medical image analysis of 
tumor progression and the development of 
programmable cells. 
• Google's DeepMind platform is being used by 
the UK National Health Service to detect 
certain health risks through data collected via 
a mobile app. A second project with the NHS 
involves analysis of medical images collected 
from NHS patients to develop computer 
vision algorithms to detect cancerous tissues. 
• Tencent is working on several medical 
systems and services. These include AI 
Medical Innovation System (AIMIS), an AI-
powered diagnostic medical imaging service; 
WeChat Intelligent Healthcare; and Tencent 
Doctorwork 
• Intel's venture capital arm Intel Capital 
recently invested in startup Lumiata which 
uses AI to identify at-risk patients and 
develop care options. 
• Kheiron Medical developed deep learning 
software to detect breast cancers in 
mammograms. 
• Fractal Analytics has incubated Qure.ai which 
focuses on using deep learning and AI to 
improve radiology and speed up the analysis 
of diagnostic x-rays. 
Digital consultant apps like Babylon Health's GP at 
Hand, Ada Health, AliHealth Doctor You, 
KareXpert and Your.MD use AI to give medical 
consultation based on personal medical history and 
common medical knowledge. Users report their 
symptoms into the app, which uses speech 
recognition to compare against a database of 
illnesses. Babylon then offers a recommended 
action, taking into account the user's medical 
history. Entrepreneurs in healthcare have been 
effectively using seven business model archetypes 
to take AI solution[buzzword] to the marketplace. 
These archetypes depend on the value generated for 
the target user (e.g. patient focus vs. healthcare 
provider and payer focus) and value capturing 
mechanisms (e.g. providing information or 
connecting stakeholders). 
IFlytek launched a service robot “Xiao Man”, 
which integrated artificial intelligence technology 
   Proceedings of Cloud based International Conference 
“Computational Systems for Health Sustainability”   
20
th
 July, 2021 Organized by Sbyte Technologies 
 
All Copyrights Reserved by sbyte.tripod.com  Page | 36 
to identify the registered customer and provide 
personalized recommendations in medical areas. It 
also works in the field of medical imaging. Similar 
robots are also being made by companies such as 
UBTECH ("Cruzr") and Softbank Robotics 
("Pepper"). The Indian startup Haptik recently 
developed a WhatsApp chatbot which answers 
questions associated with the deadly coronavirus in 
India. With the market for AI expanding 
constantly, large tech companies such as Apple, 
Google, Amazon, and Baidu all have their own AI 
research divisions, as well as millions of dollars 
allocated for acquisition of smaller AI based 
companies. Many automobile manufacturers are 
beginning to use machine learning healthcare in 
their cars as well. Companies such as BMW, GE, 
Tesla, Toyota, and Volvo all have new research 
campaigns to find ways of learning a driver's vital 
statistics to ensure they are awake, paying attention 
to the road, and not under the influence of 
substances or in emotional distress.  
CONCLUSIONS 
The use of AI is predicted to decrease medical 
costs as there will be more accuracy in diagnosis 
and better predictions in the treatment plan as well 
as more prevention of disease. Other future uses for 
AI include Brain-computer Interfaces (BCI) which 
are predicted to help those with trouble moving, 
speaking or with a spinal cord injury. The BCIs 
will use AI to help these patients move and 
communicate by decoding neural activates. 
Artificial intelligence has led to significant 
improvements in areas of healthcare such as 
medical imaging, automated clinical decision-
making, diagnosis, prognosis, and more. Although 
AI possesses the capability to revolutionize several 
fields of medicine, it still has limitations and cannot 
replace a bedside physician. 
Healthcare is a complicated science that is bound 
by legal, ethical, regulatory, economical, and social 
constraints. In order to fully implement AI within 
healthcare, there must be "parallel changes in the 
global environment, with numerous stakeholders, 
including citizen and society." 
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